The Flatiron platform can help identify the right patient cohorts for almost 15 types of cancer conditions for clinical trials, thereby optimizing clinical trial enrollment. Moreover, Flatiron's data is valuable because this real-world evidence can be used to evaluate drug efficacy and utility, a critical requirement by the FDA (regulator)..